By Vin Gurrieri ( January 13, 2016, 5:42 PM EST) -- Hospira Inc. has urged the full Federal Circuit to overrule a trial court and find that the on-sale bar, which prohibits patents on inventions that were on sale a year before the patent was filed, was triggered when The Medicines Co. paid a supplier to make numerous batches of the blood-thinning drug Angiomax....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.